Search details
1.
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides.
Cancer Immunol Immunother
; 71(4): 919-932, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34519839
2.
Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.
Blood
; 136(15): 1748-1759, 2020 10 08.
Article
in English
| MEDLINE | ID: mdl-32438399
3.
Repetitive expanded T-cell receptor clonotypes impart the classic T helper 2 Sézary cell phenotype.
Br J Dermatol
; 187(2): 265-267, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35191024
4.
Cutaneous metastasis of primary diffuse large B-cell lymphoma of the central nervous system developing 4 years after complete remission: Diagnosis confirmed by comparison of clones.
J Cutan Pathol
; 49(1): 90-94, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34498750
5.
The Course of Mycosis Fungoides under Cytokine Pathway Blockers: A Multicentre Analysis of Real-life Clinical Data.
Acta Derm Venereol
; 100(16): adv00277, 2020 09 30.
Article
in English
| MEDLINE | ID: mdl-32965506
6.
Nail Changes in Sézary Syndrome: A Single-Center Study and Review of the Literature.
J Cutan Med Surg
; 23(4): 380-387, 2019.
Article
in English
| MEDLINE | ID: mdl-30917680
7.
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial.
Lancet
; 390(10094): 555-566, 2017 08 05.
Article
in English
| MEDLINE | ID: mdl-28600132
8.
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome.
Cancer Immunol Immunother
; 67(3): 423-434, 2018 03.
Article
in English
| MEDLINE | ID: mdl-29204699
9.
Therapeutic and prognostic significance of PARP-1 in advanced mycosis fungoides and Sezary syndrome.
Exp Dermatol
; 27(2): 188-190, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29205518
10.
International Society for Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of cutaneous T-cell lymphoma outcomes during the COVID-19 pandemic: A retrospective cohort study.
J Am Acad Dermatol
; 88(4): 935-937, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36375717
11.
Dual-Positive CD4/CD8 Primary Cutaneous Peripheral T-Cell Lymphoma Previously Classified as Mycosis Fungoides a Tumor D'Emblée.
Am J Dermatopathol
; 40(11): 836-840, 2018 Nov.
Article
in English
| MEDLINE | ID: mdl-29794483
12.
The biomarker landscape in mycosis fungoides and Sézary syndrome.
Exp Dermatol
; 26(8): 668-676, 2017 08.
Article
in English
| MEDLINE | ID: mdl-27897325
13.
Hypopigmented Mycosis Fungoides with Large Cell Transformation in a Child.
Pediatr Dermatol
; 34(5): e260-e264, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28804923
14.
Cutaneous Small/Medium CD4+ Pleomorphic T-Cell Lymphoma-Like Nodule in a Patient With Erythema Chronicum Migrans.
Am J Dermatopathol
; 38(6): 448-52, 2016 Jun.
Article
in English
| MEDLINE | ID: mdl-27097344
15.
United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic.
J Am Acad Dermatol
; 83(2): 703-704, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32305443
16.
Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma.
Exp Dermatol
; 23(8): 598-600, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24862743
17.
Bullous Sweet's syndrome after granulocyte colony-stimulating factor therapy in a child with congenital neutropenia.
Pediatr Dermatol
; 31(2): e61-2, 2014.
Article
in English
| MEDLINE | ID: mdl-24387761
18.
Non-random geographic distribution of patients with cutaneous T-cell lymphoma in the Greater Pittsburgh Area.
Dermatol Online J
; 20(7)2014 Jul 15.
Article
in English
| MEDLINE | ID: mdl-25046454
19.
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon.
Blood Adv
; 8(10): 2384-2397, 2024 May 28.
Article
in English
| MEDLINE | ID: mdl-38489234
20.
Interferon-α2b-induced STAT3 suppression in myeloid-derived suppressor cells in mycosis fungoides.
Cancer Immunol Immunother
; 67(7): 1177-1178, 2018 Jul.
Article
in English
| MEDLINE | ID: mdl-29619509